(19)
(11) EP 3 962 498 A1

(12)

(43) Date of publication:
09.03.2022 Bulletin 2022/10

(21) Application number: 20798058.2

(22) Date of filing: 30.04.2020
(51) International Patent Classification (IPC): 
A61K 35/17(2015.01)
C12N 5/10(2006.01)
C07K 16/30(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 35/17; C07K 16/2878; C07K 2317/622; A61K 2039/505; A61K 2039/5156; C07K 2319/03; C07K 14/7051; C07K 2319/33; A61P 35/00; A61K 39/3955; A61K 39/001117
 
C-Sets:
  1. A61K 39/3955, A61K 2300/00;
  2. A61K 39/001117, A61K 2300/00;

(86) International application number:
PCT/US2020/030690
(87) International publication number:
WO 2020/223470 (05.11.2020 Gazette 2020/45)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 30.04.2019 US 201962840906 P

(71) Applicant: Memorial Sloan Kettering Cancer Center
New York, NY 10065 (US)

(72) Inventors:
  • SMITH, Eric, L.
    New York, NY 10065 (US)
  • BRENTJENS, Renier, J.
    New York, NY 10065 (US)

(74) Representative: Barker Brettell LLP 
100 Hagley Road Edgbaston
Birmingham B16 8QQ
Birmingham B16 8QQ (GB)

   


(54) COMBINATION THERAPIES